[Possibilities of using polychemotherapy according to the COP protocol in lymphosarcoma of the gastrointestinal tract].
Based on the use in 119 patients, the COP scheme can be regarded as an effective method of drug therapy of lymphosarcoma of the gastrointestinal tract: the total efficacy amounts to 65.4% and is practically identical in primary (61.8%) and metastatic (70%) involvement of the alimentary tube into the pathological process. However, the attainment of complete remissions was stated in an insignificant number of patients (16%). The five-year survival is equal to 60.2%.
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000008:administration & dosage; D004938:Esophageal Neoplasms / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy*; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone
Vozmozhnosti polikhimioterapii po skheme TsOP pri limfosarkome zheludochno-kishechnogo trakta.